Strides Pharma Science (STAR.BO) Earnings Analysis

Strides Pharma Science (STAR.BO) has no confirmed upcoming earnings date. It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E 17.07.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does STAR.BO next report earnings?

No confirmed upcoming earnings date is currently scheduled for STAR.BO. This page updates as the calendar is published.

STAR.BO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-1813.77 INRn/an/an/a
2026-01-3021.9 INRn/an/an/a
2025-10-2213.8 INRn/an/an/a
2025-05-228.9 INRn/an/an/a
2025-01-309.6 INRn/an/an/a
2024-10-2410.51 INR10.5 INR+0.1%Beat
2024-07-293.48 INR7.6 INR-54.2%Miss

Beat rate: 1/2 (50%) over reported quarters with consensus data.

STAR.BO valuation and analyst view

Trailing P/E17.07
Trailing EPS60.332 INR
Price / book3.06
Dividend yield0.39%
Market cap95.74B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Strides Pharma Science (STAR.BO)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for STAR.BO. This page updates as the calendar is published.

Did STAR.BO beat earnings last quarter?

Consensus estimate data was not available for STAR.BO's 2026-05-18 report.

What is STAR.BO's earnings track record?

Over the last 2 reported quarters with consensus data, STAR.BO beat estimates 1 times (50%).

What is STAR.BO's current P/E ratio and EPS?

STAR.BO trades at a trailing P/E of 17.07 on trailing EPS of 60.331818329735654 INR.

What do analysts rate STAR.BO?

STAR.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.